CN Patent

CN108815119B — 一种含有盐酸贝西沙星的药物组合物及其制备方法

Assigned to Jiangsu Yabang Aipusen Pharmaceutical Co ltd · Expires 2022-09-27 · 4y expired

What this patent protects

本发明公开了一种含有盐酸贝西沙星的药物组合物及其制备方法，其处方包含如下质量百分数的组分：盐酸贝西沙星5%~10%，两亲性嵌段聚合物载体5%~65%，抑菌剂0.01%~2%，增稠剂0.01%~20%，渗透压调节剂0.01%~40%，pH调节剂0.01%~10%，金属离子螯合剂0.01%~2%和注射用水。所制备的盐酸贝西沙星滴眼剂的稳定性好，可显著延长盐酸贝西沙星在眼内的作用时间，提高其疗效。

USPTO Abstract

本发明公开了一种含有盐酸贝西沙星的药物组合物及其制备方法，其处方包含如下质量百分数的组分：盐酸贝西沙星5%~10%，两亲性嵌段聚合物载体5%~65%，抑菌剂0.01%~2%，增稠剂0.01%~20%，渗透压调节剂0.01%~40%，pH调节剂0.01%~10%，金属离子螯合剂0.01%~2%和注射用水。所制备的盐酸贝西沙星滴眼剂的稳定性好，可显著延长盐酸贝西沙星在眼内的作用时间，提高其疗效。

Drugs covered by this patent

Patent Metadata

Patent number
CN108815119B
Jurisdiction
CN
Classification
—
Expires
2022-09-27
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Yabang Aipusen Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.